Salvatore Emma Jr., CEO/President at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 2,500 shares at $3.94 ($10K) on 2016-03-15, disclosed to the SEC on 2016-03-17.
Open-market purchase of $10k HRT by CEO/President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.85 | 586 | $2K | 23.0% |
| 2 | $3.94 | 1,914 | $8K | 77.0% |
| Total | $3.92 avg | 2,500 | $10K | 100% |
| Filing → |
| HRT | BUY | 2015-06-16 | $7K | — | Filing → |
| HRT | SELL | 2014-08-20 | $94K | — | Filing → |